111 related articles for article (PubMed ID: 18949393)
1. Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.
Bendardaf R; Lamlum H; Ristamäki R; Syrjänen K; Pyrhönen S
Oncol Rep; 2008 Nov; 20(5):999-1004. PubMed ID: 18949393
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475
[TBL] [Abstract][Full Text] [Related]
3. Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer.
Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
Tumour Biol; 2007; 28(4):212-20. PubMed ID: 17717427
[TBL] [Abstract][Full Text] [Related]
4. The mismatch repair protein status of colorectal small cell neuroendocrine carcinomas.
Stelow EB; Moskaluk CA; Mills SE
Am J Surg Pathol; 2006 Nov; 30(11):1401-4. PubMed ID: 17063080
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
[TBL] [Abstract][Full Text] [Related]
6. [Microsatellite analysis and hMLH1/hMSH2 expression detection in young patients with colorectal cancer: value in screening hereditary nonpolyposis colorectal cancer].
Yang L; Ding YQ; Li GX; Yu J; Wang Y; Zhou J; Yang HJ; Zhang JH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):779-82. PubMed ID: 17584637
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial genomic instability in colorectal cancer: no correlation to nuclear microsatellite instability and allelic deletion of hMSH2, hMLH1, and p53 genes, but prediction of better survival for Dukes' stage C disease.
Tsai MH; Fang WH; Lin SW; Yen SJ; Chou SJ; Yang YC
Ann Surg Oncol; 2009 Oct; 16(10):2918-25. PubMed ID: 19582509
[TBL] [Abstract][Full Text] [Related]
8. Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.
Brueckl WM; Moesch C; Brabletz T; Koebnick C; Riedel C; Jung A; Merkel S; Schaber S; Boxberger F; Kirchner T; Hohenberger W; Hahn EG; Wein A
Anticancer Res; 2003; 23(2C):1773-7. PubMed ID: 12820457
[TBL] [Abstract][Full Text] [Related]
9. Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.
Bendardaf R; Sharif-Askari FS; Sharif-Askari NS; Syrjänen K; Pyrhönen S
Anticancer Res; 2018 Nov; 38(11):6399-6404. PubMed ID: 30396964
[TBL] [Abstract][Full Text] [Related]
10. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
Ohrling K; Edler D; Hallström M; Ragnhammar P
Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
[TBL] [Abstract][Full Text] [Related]
11. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
[TBL] [Abstract][Full Text] [Related]
12. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
13. hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps.
Balbinotti RA; Ribeiro U; Sakai P; Safatle-Ribeiro AV; Balbinotti SS; Scapulatempo C; Alves VA; Corbett CE; Carrilho FJ
Anticancer Res; 2007; 27(6C):4465-71. PubMed ID: 18214062
[TBL] [Abstract][Full Text] [Related]
14. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
16. Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.
Ma J; Zhang Y; Shen H; Kapesa L; Liu W; Zeng M; Zeng S
Tumour Biol; 2015 Dec; 36(12):9599-609. PubMed ID: 26142736
[TBL] [Abstract][Full Text] [Related]
17. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.
Olasz J; Mándoky L; Géczi L; Bodrogi I; Csuka O; Bak M
Anticancer Res; 2005; 25(6B):4319-24. PubMed ID: 16309235
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
Catto JW; Xinarianos G; Burton JL; Meuth M; Hamdy FC
Int J Cancer; 2003 Jul; 105(4):484-90. PubMed ID: 12712438
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and hMLH1 and hMSH2 expression analysis in soft tissue sarcomas.
Kawaguchi K; Oda Y; Takahira T; Saito T; Yamamoto H; Kobayashi C; Tamiya S; Oda S; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2005 Feb; 13(2):241-6. PubMed ID: 15643505
[TBL] [Abstract][Full Text] [Related]
20. Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas.
Gu MJ; Bae YK; Kim A; Hong SM; Yu E; Kim J; Jang KT; Chang HK; Jung ES; Bae HI; Yoon GS; Kim JM; Kim JY; Kim GI; Oh YH; Jang KY; Jun SY; Eom DW; Kwon KW; Kang GH; Park JB; Hong SW; Jung SJ; Lee JS;
Hepatogastroenterology; 2012 Oct; 59(119):2228-32. PubMed ID: 22456432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
